is contrave a glp 1 drug Sharing some information on one of oral medications for medical weight loss. Contrave® an FDA-approved oral medication that combines naltrexone + bupropion to help target appetite and food cravings at the GLP-1 receptor agonists | How
Description
doi: 10.2337/dc06-2375

Publishers note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

These are typical mean (average) results

Sitagliptin use in patients with diabetes and heart failure: A population-based retrospective cohort study

If additional glycemic control is required after one week, the dosage may be increased to 1.2 mg daily
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
Boland et al
